BioTiChe achieves first milestone in agreement with Autifony Therapeutics

BioTiChe today announced the successful achievement of the first milestone under its agreement with Autifony Therapeutics. While details remain confidential, this milestone marks an important step forward in our R&D efforts and highlights the strength of BioTiChe’s integrated chemistry and biology teams, as well as its commitment to scientific excellence. Dr. Giuseppe Alvaro, Chief Executive […]

BioTiChe announces publication study in Acta Neuropathologica Communications, revealing a novel role for Kv3 channels in ALS

BioTiChe today announced the publication of a peer-reviewed article titled “Kv3 channel agonist ameliorates the phenotype of a mouse model of amyotrophic lateral sclerosis” in Acta Neuropathologica Communications. The article is available here The study was conducted through a collaboration led by Prof. Maria Pennuto at the University of Padua, in partnership with Autifony Therapeutics. […]